Drug-Approval, page 7

Search results for Drug-Approval

Found 1703 articles. Showing from 61 to 70.

Clinical cancer research (2012-09-07)
U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma.

Revista de calidad asistencial (2012-07-11)
[Off-label approval of drug use in a tertiary hospital].

The Journal of allergy and clinical immunology (2003-01-17)
Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter Olympics.

Nature reviews. Rheumatology (2012-09-11)
Rheumatoid arthritis: Threshold for success in RA drug development.

Expert opinion on biological therapy (2008-04-14)
The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis.

Gastroenterology (2013-03-04)
Earlier Sustained Virologic Response Endpoints for Regulatory Approval and Dose Selection of Hepatitis C Therapies.

The oncologist (2012-09-21)
U.S. Food and Drug Administration Approval: peginterferon-alfa-2b for the adjuvant treatment of patients with melanoma.

Clinical cancer research (2006-09-26)
Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma.

Advances in health economics and health services research (2012-11-19)
Effects of regulation on drug launch and pricing in interdependent markets.

Archives of general psychiatry (2005-04-05)
Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.

Filters

Journals

Categories

Subjects

Year of publication

Español | English

© Galenicom 1999-2013